Chosa Oncology AB (FRA:W5L) E10: €-0.11 (As of Mar. 2026)


FRA:W5L Chosa Oncology AB FRA:W5L
31 GF Score
Price €0.06
View Full Analysis

What is Chosa Oncology AB E10?

Chosa Oncology AB FRA:W5L 31 E10 is €-0.11 as of Mar. 2026. GuruFocus rates FRA:W5L with a GF Score™ of 31/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Chosa Oncology AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.11 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-30), Chosa Oncology AB's current stock price is €0.0628. Chosa Oncology AB's E10 for the quarter that ended in Mar. 2026 was €-0.11. Chosa Oncology AB's Shiller PE Ratio of today is .


Chosa Oncology AB  (FRA:W5L) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Chosa Oncology AB E10 Related Terms


Chosa Oncology AB E10 Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB E10 Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.14

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -0.13 -0.11 -0.14 -0.11

FRA:W5L vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Chosa Oncology AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chosa Oncology AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Chosa Oncology AB's Shiller PE Ratio falls into.


FRA:W5L
31GF Score
Chosa Oncology AB FRA:W5L
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chosa Oncology AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chosa Oncology AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.002/133.3862*133.3862
=-0.002

Current CPI (Mar. 2026) = 133.3862.

Chosa Oncology AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.029 101.019 -0.038
201609 -0.048 101.138 -0.063
201612 -0.040 102.022 -0.052
201703 -0.031 102.022 -0.041
201706 -0.026 102.752 -0.034
201709 -0.041 103.279 -0.053
201712 -0.032 103.793 -0.041
201803 -0.038 103.962 -0.049
201806 -0.036 104.875 -0.046
201809 -0.046 105.679 -0.058
201812 -0.056 105.912 -0.071
201903 -0.054 105.886 -0.068
201906 -0.192 106.742 -0.240
201909 -0.049 107.214 -0.061
201912 0.008 107.766 0.010
202003 -0.028 106.563 -0.035
202006 -0.040 107.498 -0.050
202009 -0.050 107.635 -0.062
202012 -0.072 108.296 -0.089
202103 -0.041 108.360 -0.050
202106 -0.047 108.928 -0.058
202109 -0.077 110.338 -0.093
202112 -0.099 112.486 -0.117
202203 -0.067 114.825 -0.078
202206 -0.079 118.384 -0.089
202209 0.061 122.296 0.067
202212 0.129 126.365 0.136
202303 -0.022 127.042 -0.023
202306 -0.004 129.407 -0.004
202309 -0.079 130.224 -0.081
202312 -0.004 131.912 -0.004
202403 -0.002 132.205 -0.002
202406 -0.002 132.716 -0.002
202409 -0.027 132.304 -0.027
202412 0.001 132.987 0.001
202503 -0.002 132.825 -0.002
202506 0.003 133.699 0.003
202509 -0.003 133.482 -0.003
202512 0.001 133.386 0.001
202603 -0.002 133.386 -0.002

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.11 mean?
Chosa Oncology AB (FRA:W5L) has a E10 of €-0.11 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Chosa Oncology AB and its competitors.
Is Chosa Oncology AB's E10 too high?
Chosa Oncology AB's current E10 is €-0.11. Overall, Chosa Oncology AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's E10 compare to VRTX and REGN?
Chosa Oncology AB's E10 of €-0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Chosa Oncology AB and its competitors. Chosa Oncology AB's current E10 is €-0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (FRA:W5L) has a current E10 of €-0.11. The current E10 is €-0.11. Chosa Oncology AB's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Chosa Oncology AB (FRA:W5L), the current E10 is €-0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Other Exchanges CHOSA:Sweden
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
31GF Score

Get the complete analysis for FRA:W5L

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price